Fulgent Genetics: Reggie Groves

Fulgent Genetics has added Reggie Groves to its board of directors, effective Jan. 3, 2023. Groves previously served in executive positions at Stimwave, REVA Medical, and Medtronic. She also has expertise in profit and loss responsibility for a publicly traded company, Fulgent said. Groves currently serves on the boards of Advanced NanoTherapies and AtriCure, a publicly traded company. She holds a BS in pharmacy from the University of Florida and an MBA from Harvard Graduate School of Business Administration.